MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Parkinson’s Disease Presentation in Calabar, Nigeria

    S. Oparah, U. Williams, J. Mwankon (Calabar, Nigeria)

    Objective: To create a database and describe the presentation of Parkinson's disease patients at the sole tertiary hospital in Calabar, southern Nigeria. Background: Parkinson's disease…
  • 2019 International Congress

    Identifying healthy Parkin mutation carriers based on sensor-based posturography and gait analysis

    J. Prasuhn, M. Borsche, A. Hicks, M. Gögele, C. Egger, C. Kritzinger, L. Langlott, M. Kasten, C. Klein, P. Pramstaller, N. Brüggemann (Lübeck, Germany)

    Objective: To discriminate healthy Parkin mutation carriers from healthy non-mutation carriers using sensor-based motion analysis. Background: Identifying endophenotypes for PD is crucial for testing potential…
  • 2019 International Congress

    Stereopsis as a Visual Biomarker for Parkinson’s Disease

    T. Sang, J. Fatehi, E. Mostofi, B. Zheng, F. Ba (Edmonton, AB, Canada)

    Objective: 1): To assess Parkinson’s disease (PD) patients’ stereopsis function using better and more physiologically meaningful tools; 2): To reveal specific eye behaviors of stereoacuity…
  • 2019 International Congress

    Serological analysis of circulating Alpha Synuclein protein levels by Surface Plasmon Resonance (SPR) In Parkinson’s disease

    A. Singh, T. Bajaj, A. Dey, S. Dey (New Delhi, India)

    Objective: α-synuclein (α-Syn) is a presynaptic protein whose overexpression or misfolding contributes to the pathophysiology of Parkinson’s disease (PD). This study aims to estimate the…
  • 2019 International Congress

    Does Anticholinergic Burden Affect the Outcomes in Patients Diagnosed with Parkinson’s Disease?

    S. Taylor, E. Jones (York, United Kingdom)

    Objective: To explore the impact of an anticholinergic burden on various outcomes in Parkinson’s disease. Background: Over 600 different medications possess some anticholinergic effect.[1] There…
  • 2019 International Congress

    APOmorphine infusion and aMYLoid deposition in Parkinson’s disease (APOMYL): preliminary clinical and amyloid imaging data

    D. van Wamelen, M. Politis, D. Aarsland, P. Odin, T. van Laar, T. Henriksen, B. Corcoran, G. Vivian, H. Wilson, M. Parry, A. Sauerbier, N. Mulholland, K. Chaudhuri (London, United Kingdom)

    Objective: To explore the potential effects of chronic Apomorphine infusion treatment on reducing brain Amyloid-b (Aβ) deposition in Parkinson’s disease (PD). Background: A majority of…
  • 2019 International Congress

    The relationship between constipation and alteration of gut microbiota in patients with Parkinson’s disease

    BI. Zao An, M. Ye (Nanjing, China)

    Objective: To  study compositional and functional differences  in the gut microbiota  and its products between  individuals with PD and matched controls,and these differences  are  or…
  • 2019 International Congress

    Initial Validation of the Cortical Basal ganglia Functional Scale (CBFS) in two international, multicenter cohorts: 4RTNI and PROSPECT

    A. Boxer, P. Wang, H. Morris, G. Stebbins, A. Lang (Toronto, ON, Canada)

    Objective: To assess the validity of a patient/caregiver-reported scale for assessing functional disability in 4R tauopathies. Background: 4R tauopathies (4RT) including progressive supranuclear palsy (PSP),…
  • 2019 International Congress

    Serotonergic function in De Novo Parkinson’s Disease

    HK. Park, JJ. Lee, YM. Park (Goyang, Republic of Korea)

    Objective: We aimed to investigate the central serotonergic function in de novo PD and change in serotonergic function with dopaminergic medications. Background: While dopaminergic dysfunction…
  • 2019 International Congress

    Carpal Tunnel Syndrome in Patients with Tremor

    L. Jackson, F. Ali (Rochester, MN, USA)

    Objective: To determine whether patients who present with tremor have an increased risk of carpal tunnel syndrome (CTS). Background: Carpal tunnel syndrome is the most…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley